Genus plc (GENSY)
OTCMKTS · Delayed Price · Currency is USD
42.84
+0.37 (0.87%)
At close: Feb 11, 2026
Genus Employees
Genus had 3,190 employees as of June 30, 2025. The number of employees decreased by 310 or -8.86% compared to the previous year.
Employees
3,190
Change (1Y)
-310
Growth (1Y)
-8.86%
Revenue / Employee
$288,956
Profits / Employee
$8,289
Market Cap
2.81B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 3,190 | -310 | -8.86% |
| Jun 30, 2024 | 3,500 | 0 | - |
| Jun 30, 2023 | 3,500 | 0 | - |
| Jun 30, 2022 | 3,500 | 100 | 2.94% |
| Jun 30, 2021 | 3,400 | 300 | 9.68% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |